microRNA 6511b-2 (MIR6511B2)

microRNA 6511b-2 is a member of the mir-6511 microRNA precursor family, and its predicted precursor sequence in Homo sapiens is denoted as hsa-mir-6511b-2[6]. Like other microRNAs, it is a small, non-coding RNA molecule involved in post-transcriptional regulation of gene expression through base-pairing with target messenger RNAs, leading to their silencing or degradation[5]. The mir-6511b-2 locus has been annotated in sequence databases but does not currently have published functional studies, validated biological roles, or disease associations. It is not recognized as a therapeutic target, receptor, enzyme, transporter, or other classical druggable protein family. There is insufficient information about its mature sequence, specific mechanism, related biomarkers, safety profile, or drug interactions. The entry is likely incomplete or based primarily on computational annotation, as opposed to experimental validation[6]. The absence of literature describing biological targets, functions, or disease implications or use in drug targeting indicates the molecule is not considered a pharmaceutical target[6]. The lack of known biological function and its absence from curated disease or drug databases suggest that microRNA 6511b-2 is not a recognized functional target. This means requesting therapeutic targeting or disease-modulating roles for microRNA 6511b-2 would be incorrect at present, due to missing experimental data or published validation[6]. More well-characterized microRNAs are frequently used in cancer and disease molecular profiling, but there is currently no such evidence for mir-6511b-2[1][2][3][5].

Other names

hsa-mir-6511b-2MIR6511B-2microRNA mir-6511b-2mir-6511b-2MIR6511B2